etrials Adds Three New Trials for Top Ten Pharmaceutical Clients Company Supplies Patient Diary Technology to Over 4,000 New Patients
etrials Worldwide, Inc., the first company to offer fully integrated, easy-to-use eClinical software for the clinical trial process, today announced that it has added three new studies for top ten pharmaceutical companies. All three trials will use etrials' electronic patient diary technology on handheld devices (PDAs) to electronically capture patient reported outcomes (ePRO).
etrials Worldwide, Inc., the first company to offer fully integrated, easy-to-use eClinical software for the clinical trial process, today announced that it has added three new studies for top ten pharmaceutical companies. All three trials will use etrials' electronic patient diary technology on handheld devices (PDAs) to electronically capture patient reported outcomes (ePRO).
Two of the new studies are Phase III, women's health trials which will include 300 sites and approximately 4,000 patients. The third new trial is a Phase IIIb Neurology study which will include 20 sites and over 300 patients. etrials? ePRO devices will be distributed to patients participating in the studies to record and submit trial data remotely as well as used for site-based collection of data.
"As more emphasis is placed on faster access to critical patient data we have seen many of the top pharmaceutical companies making great strides in implementing eClinical technology in a variety of studies, across multiple trials and in all therapeutic areas," said John Cline, CEO of etrials. "Having the opportunity to work with many of the top ten pharmaceutical companies enables etrials to further demonstrate its unique ability to offer fully integrated and easy-to-use technology and the important efficiencies gained through the use of eClinical technology."
About etrials Worldwide, Inc.
etrials is a software and services company dedicated to making eClinical easy. We are the first company to offer a fully integrated suite of eClinical software including electronic data capture (EDC), electronic patient reported outcomes (ePRO), interactive voice response (IVR) and analytics to support the entire clinical trial process, from collection and cleaning to the integration and review of data. Our expertise includes studies from Phase I to post-approval for pharmaceutical, biotechnology and clinical research organizations. To date, our team of professionals has participated in over 450 clinical trials in more than 50 different countries.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Zerlasiran Achieves Significant Sustained Reduction in Lipoprotein(a) Levels with Infrequent Dosing
November 20th 2024Zerlasiran, a novel siRNA therapy, demonstrated over 80% sustained reductions in lipoprotein(a) levels with infrequent dosing in the Phase II ALPACAR-360 trial, highlighting its potential as a safe and effective treatment for patients at high risk of cardiovascular disease.
